US 12,227,541 B2
Sterol derivatives and preparation method and uses thereof
Zhenwen Duan, Beijing (CN); Shuren Guo, Beijing (CN); and Xuemei Li, Beijing (CN)
Assigned to BEIJING PEKING UNIVERSITY WBL BIOTECH CO., LTD., Beijing (CN)
Filed by BEIJING PEKING UNIVERSITY WBL BIOTECH CO., LTD., Beijing (CN)
Filed on Oct. 15, 2020, as Appl. No. 17/071,958.
Application 17/071,958 is a continuation of application No. 14/368,494, granted, now 10,889,612, previously published as PCT/CN2012/087360, filed on Dec. 25, 2012.
Claims priority of application No. 201110441993.2 (CN), filed on Dec. 26, 2011; application No. 201110442009.4 (CN), filed on Dec. 26, 2011; and application No. 201210015475.9 (CN), filed on Jan. 18, 2012.
Prior Publication US 2021/0024570 A1, Jan. 28, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C07J 71/00 (2006.01); A61K 31/58 (2006.01); A61K 36/06 (2006.01); A61K 36/899 (2006.01); A61P 35/00 (2006.01)
CPC C07J 71/0005 (2013.01) [A61K 31/58 (2013.01); A61K 36/06 (2013.01); A61K 36/899 (2013.01); A61P 35/00 (2018.01); A61K 2236/00 (2013.01)] 4 Claims
OG exemplary drawing
 
1. A pharmaceutical composition comprising:
(i) an HMG-COA reductase inhibitor consisting of a compound of Formula (II):

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt, ester or ether thereof; and
(ii) one or more pharmaceutically acceptable carrier or excipient.